Changes in life expectancy and disease burden in Norway, 1990-2019: an analysis of the Global Burden of Disease Study 2019.

Benjamin Clarsen, Magne Nylenna, Søren Toksvig Klitkou, Stein Emil Vollset, Carl Michael Baravelli, Anette Kocbach Bølling, Gunn Marit Aasvang, Gerhard Sulo, Mohsen Naghavi, Maja Pasovic, Muhammad Asaduzzaman, Tone Bjørge, Anne Elise Eggen, Terje Andreas Eikemo, Christian Lycke Ellingsen, Øystein Ariansen Haaland, Alemayehu Hailu, Shoaib Hassan, Simon I Hay, Petur B Juliusson, Adnan Kisa, Sezer Kisa, Johan Månsson, Teferi Mekonnen, Christopher J L Murray, Ole F Norheim, Trygve Ottersen, Dominic Sagoe, Kam Sripada, Andrea Sylvia Winkler, Ann Kristin Skrindo Knudsen
{"title":"Changes in life expectancy and disease burden in Norway, 1990-2019: an analysis of the Global Burden of Disease Study 2019.","authors":"Benjamin Clarsen,&nbsp;Magne Nylenna,&nbsp;Søren Toksvig Klitkou,&nbsp;Stein Emil Vollset,&nbsp;Carl Michael Baravelli,&nbsp;Anette Kocbach Bølling,&nbsp;Gunn Marit Aasvang,&nbsp;Gerhard Sulo,&nbsp;Mohsen Naghavi,&nbsp;Maja Pasovic,&nbsp;Muhammad Asaduzzaman,&nbsp;Tone Bjørge,&nbsp;Anne Elise Eggen,&nbsp;Terje Andreas Eikemo,&nbsp;Christian Lycke Ellingsen,&nbsp;Øystein Ariansen Haaland,&nbsp;Alemayehu Hailu,&nbsp;Shoaib Hassan,&nbsp;Simon I Hay,&nbsp;Petur B Juliusson,&nbsp;Adnan Kisa,&nbsp;Sezer Kisa,&nbsp;Johan Månsson,&nbsp;Teferi Mekonnen,&nbsp;Christopher J L Murray,&nbsp;Ole F Norheim,&nbsp;Trygve Ottersen,&nbsp;Dominic Sagoe,&nbsp;Kam Sripada,&nbsp;Andrea Sylvia Winkler,&nbsp;Ann Kristin Skrindo Knudsen","doi":"10.1016/S2468-2667(22)00092-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Geographical differences in health outcomes are reported in many countries. Norway has led an active policy aiming for regional balance since the 1970s. Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties.</p><p><strong>Methods: </strong>Data for life expectancy, healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) in Norway and its 11 counties from 1990 to 2019 were extracted from GBD 2019. County-specific contributors to changes in life expectancy were compared. Inequality in disease burden was examined by use of the Gini coefficient.</p><p><strong>Findings: </strong>Life expectancy and HALE improved in all Norwegian counties from 1990 to 2019. Improvements in life expectancy and HALE were greatest in the two counties with the lowest values in 1990: Oslo, in which life expectancy and HALE increased from 71·9 years (95% uncertainty interval 71·4-72·4) and 63·0 years (60·5-65·4) in 1990 to 81·3 years (80·0-82·7) and 70·6 years (67·4-73·6) in 2019, respectively; and Troms og Finnmark, in which life expectancy and HALE increased from 71·9 years (71·5-72·4) and 63·5 years (60·9-65·6) in 1990 to 80·3 years (79·4-81·2) and 70·0 years (66·8-72·2) in 2019, respectively. Increased life expectancy was mainly due to reductions in cardiovascular disease, neoplasms, and respiratory infections. No significant differences between the national YLD or DALY rates and the corresponding age-standardised rates were reported in any of the counties in 2019; however, Troms og Finnmark had a higher age-standardised YLL rate than the national rate (8394 per 100 000 [95% UI 7801-8944] vs 7536 per 100 000 [7391-7691]). Low inequality between counties was shown for life expectancy, HALE, all level-1 causes of DALYs, and exposure to level-1 risk factors.</p><p><strong>Interpretation: </strong>Over the past 30 years, Norway has reduced inequality in disease burden between counties. However, inequalities still exist at a within-county level and along other sociodemographic gradients. Because of insufficient Norwegian primary data, there remains substantial uncertainty associated with regional estimates for non-fatal disease burden and exposure to risk factors.</p><p><strong>Funding: </strong>Bill & Melinda Gates Foundation, Research Council of Norway, and Norwegian Institute of Public Health.</p>","PeriodicalId":431786,"journal":{"name":"The Lancet. Public health","volume":" ","pages":"e593-e605"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253891/pdf/","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Public health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/S2468-2667(22)00092-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Background: Geographical differences in health outcomes are reported in many countries. Norway has led an active policy aiming for regional balance since the 1970s. Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties.

Methods: Data for life expectancy, healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) in Norway and its 11 counties from 1990 to 2019 were extracted from GBD 2019. County-specific contributors to changes in life expectancy were compared. Inequality in disease burden was examined by use of the Gini coefficient.

Findings: Life expectancy and HALE improved in all Norwegian counties from 1990 to 2019. Improvements in life expectancy and HALE were greatest in the two counties with the lowest values in 1990: Oslo, in which life expectancy and HALE increased from 71·9 years (95% uncertainty interval 71·4-72·4) and 63·0 years (60·5-65·4) in 1990 to 81·3 years (80·0-82·7) and 70·6 years (67·4-73·6) in 2019, respectively; and Troms og Finnmark, in which life expectancy and HALE increased from 71·9 years (71·5-72·4) and 63·5 years (60·9-65·6) in 1990 to 80·3 years (79·4-81·2) and 70·0 years (66·8-72·2) in 2019, respectively. Increased life expectancy was mainly due to reductions in cardiovascular disease, neoplasms, and respiratory infections. No significant differences between the national YLD or DALY rates and the corresponding age-standardised rates were reported in any of the counties in 2019; however, Troms og Finnmark had a higher age-standardised YLL rate than the national rate (8394 per 100 000 [95% UI 7801-8944] vs 7536 per 100 000 [7391-7691]). Low inequality between counties was shown for life expectancy, HALE, all level-1 causes of DALYs, and exposure to level-1 risk factors.

Interpretation: Over the past 30 years, Norway has reduced inequality in disease burden between counties. However, inequalities still exist at a within-county level and along other sociodemographic gradients. Because of insufficient Norwegian primary data, there remains substantial uncertainty associated with regional estimates for non-fatal disease burden and exposure to risk factors.

Funding: Bill & Melinda Gates Foundation, Research Council of Norway, and Norwegian Institute of Public Health.

1990-2019年挪威预期寿命和疾病负担的变化:2019年全球疾病负担研究分析
背景:许多国家报告了健康结果的地理差异。自20世纪70年代以来,挪威领导了旨在实现地区平衡的积极政策。利用2019年全球疾病负担研究(GBD)的数据,我们研究了挪威各县在发展和健康状况方面的区域差异。方法:从GBD 2019中提取挪威及其11个县1990 - 2019年的预期寿命、健康预期寿命(HALE)、生命损失年数(YLLs)、残疾生存年数(YLDs)和残疾调整生命年(DALYs)数据。对影响预期寿命变化的特定国家进行了比较。用基尼系数检验了疾病负担的不平等。研究结果:从1990年到2019年,挪威所有县的预期寿命和HALE都有所改善。预期寿命和HALE在1990年最低的两个县的改善最大:奥斯陆,其预期寿命和HALE分别从1990年的71.9岁(95%不确定区间74.1 - 72.4)和60.3岁(60.5 - 65.4)增加到2019年的83.1岁(800.4 - 82.7)和70.6岁(64.7 - 73.6);芬兰马克的Troms和HALE分别从1990年的71.9岁(71.5 ~ 72.4岁)和63.5岁(60.9 ~ 66.5岁)增加到2019年的80.3岁(79.4 ~ 81.2岁)和70.7岁(66.8 ~ 77.2岁)。预期寿命的延长主要是由于心血管疾病、肿瘤和呼吸道感染的减少。各县2019年全国YLD和DALY与相应的年龄标准化率均无显著差异;然而,特罗姆斯和芬兰马克的年龄标准化YLL率高于全国水平(8394 / 10万[95% UI 7801-8944] vs 7536 / 10万[7391-7691])。郡县之间在预期寿命、HALE、DALYs的所有一级原因以及暴露于一级风险因素方面的不平等程度较低。解释:在过去的30年里,挪威减少了县与县之间疾病负担的不平等。然而,在县内一级和其他社会人口梯度上仍然存在不平等。由于挪威的原始数据不足,对非致命性疾病负担和风险因素暴露的区域估计仍存在很大的不确定性。资助:比尔和梅林达·盖茨基金会、挪威研究理事会和挪威公共卫生研究所。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信